A general process for the development of peptide-based immunoassays for monoclonal antibodies

Ana B. Sánchez(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Bradley T. Messmer(Harvard University), Tammy Nguyen(University of Utah), Andrew C. Kummel(University of California San Diego), Thomas J. Kipps(University of California San Diego), Rhanika Dema-Ala(University of California San Diego)
Cancer Chemotherapy and Pharmacology
January 19, 2010
10.1007/s00280-009-1240-1
Cited by 19

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k